Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment
Clinical trial NCT03443063 · COMPLETED
Trial details
- NCT number
- NCT03443063
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-07
- Primary completion
- 2018-08-24
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.